200 related articles for article (PubMed ID: 38698238)
1. Predictability of B cell clonal persistence and immunosurveillance in breast cancer.
Sammut SJ; Galson JD; Minter R; Sun B; Chin SF; De Mattos-Arruda L; Finch DK; Schätzle S; Dias J; Rueda OM; Seoane J; Osbourn J; Caldas C; Bashford-Rogers RJM
Nat Immunol; 2024 May; 25(5):916-924. PubMed ID: 38698238
[TBL] [Abstract][Full Text] [Related]
2. Clonal distribution and intratumour heterogeneity of the B-cell repertoire in oesophageal squamous cell carcinoma.
Zhang C; Huang H; Miao Y; Xiong H; Lu Z
J Pathol; 2018 Nov; 246(3):323-330. PubMed ID: 30027584
[TBL] [Abstract][Full Text] [Related]
3. Immune repertoire: A potential biomarker and therapeutic for hepatocellular carcinoma.
Han Y; Li H; Guan Y; Huang J
Cancer Lett; 2016 Sep; 379(2):206-12. PubMed ID: 26188280
[TBL] [Abstract][Full Text] [Related]
4. Impact of T-cell receptor and B-cell receptor repertoire on the recurrence of early stage lung adenocarcinoma.
Liu J; Yang X; Lu X; Zhang L; Luo W; Cheng Y; Zhang L; Yang Y; Dai N; Xu Y; Guan Y; Xiao H; Li M; Wang D
Exp Cell Res; 2020 Sep; 394(2):112134. PubMed ID: 32540399
[TBL] [Abstract][Full Text] [Related]
5. T and B Cell Receptor Immune Repertoire Analysis using Next-generation Sequencing.
Werner L; Dor C; Salamon N; Nagar M; Shouval DS
J Vis Exp; 2021 Jan; (167):. PubMed ID: 33522509
[TBL] [Abstract][Full Text] [Related]
6. Single-cell immune repertoire analysis.
Irac SE; Soon MSF; Borcherding N; Tuong ZK
Nat Methods; 2024 May; 21(5):777-792. PubMed ID: 38637691
[TBL] [Abstract][Full Text] [Related]
7. Immune repertoire analysis is gaining interest as a clinical NGS application.
Brunstein J
MLO Med Lab Obs; 2016 Oct; 48(10):26-27. PubMed ID: 30047649
[No Abstract] [Full Text] [Related]
8. Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells.
Corthay A; Lundin KU; Lorvik KB; Hofgaard PO; Bogen B
Cancer Res; 2009 Jul; 69(14):5901-7. PubMed ID: 19567679
[TBL] [Abstract][Full Text] [Related]
9. Alterations in T and B Cell Receptor Repertoires Patterns in Patients With IL10 Signaling Defects and History of Infantile-Onset IBD.
Werner L; Lee YN; Rechavi E; Lev A; Yerushalmi B; Ling G; Shah N; Uhlig HH; Weiss B; Somech R; Snapper SB; Shouval DS
Front Immunol; 2020; 11():109. PubMed ID: 32117262
[TBL] [Abstract][Full Text] [Related]
10. Genetics of B and T cell recognition.
Nowak JS
Acta Anthropogenet; 1985; 9(1-3):1-19. PubMed ID: 2956972
[TBL] [Abstract][Full Text] [Related]
11. Survival of the fetus: fetal B and T cell receptor repertoire development.
Rechavi E; Somech R
Semin Immunopathol; 2017 Nov; 39(6):577-583. PubMed ID: 28466095
[TBL] [Abstract][Full Text] [Related]
12. The evolution of adaptive immunity.
Danilova N
Adv Exp Med Biol; 2012; 738():218-35. PubMed ID: 22399382
[TBL] [Abstract][Full Text] [Related]
13. [Adaptive immunity].
Kamradt T; Ferrari-Kühne K
Dtsch Med Wochenschr; 2011 Aug; 136(33):1678-83. PubMed ID: 21833893
[No Abstract] [Full Text] [Related]
14. Learning the High-Dimensional Immunogenomic Features That Predict Public and Private Antibody Repertoires.
Greiff V; Weber CR; Palme J; Bodenhofer U; Miho E; Menzel U; Reddy ST
J Immunol; 2017 Oct; 199(8):2985-2997. PubMed ID: 28924003
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma.
Dong LQ; Peng LH; Ma LJ; Liu DB; Zhang S; Luo SZ; Rao JH; Zhu HW; Yang SX; Xi SJ; Chen M; Xie FF; Li FQ; Li WH; Ye C; Lin LY; Wang YJ; Wang XY; Gao DM; Zhou H; Yang HM; Wang J; Zhu SD; Wang XD; Cao Y; Zhou J; Fan J; Wu K; Gao Q
J Hepatol; 2020 May; 72(5):896-908. PubMed ID: 31887370
[TBL] [Abstract][Full Text] [Related]
16. Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens.
Linette GP; Becker-Hapak M; Skidmore ZL; Baroja ML; Xu C; Hundal J; Spencer DH; Fu W; Cummins C; Robnett M; Kaabinejadian S; Hildebrand WH; Magrini V; Demeter R; Krupnick AS; Griffith OL; Griffith M; Mardis ER; Carreno BM
Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23662-23670. PubMed ID: 31685621
[TBL] [Abstract][Full Text] [Related]
17. T cell receptor repertoire usage in cancer as a surrogate marker for immune responses.
Schrama D; Ritter C; Becker JC
Semin Immunopathol; 2017 Apr; 39(3):255-268. PubMed ID: 28074285
[TBL] [Abstract][Full Text] [Related]
18. Induction of Neoantigen-Specific Cytotoxic T Cells and Construction of T-cell Receptor-Engineered T Cells for Ovarian Cancer.
Matsuda T; Leisegang M; Park JH; Ren L; Kato T; Ikeda Y; Harada M; Kiyotani K; Lengyel E; Fleming GF; Nakamura Y
Clin Cancer Res; 2018 Nov; 24(21):5357-5367. PubMed ID: 29720506
[No Abstract] [Full Text] [Related]
19. Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer.
Tchou J; Zhao Y; Levine BL; Zhang PJ; Davis MM; Melenhorst JJ; Kulikovskaya I; Brennan AL; Liu X; Lacey SF; Posey AD; Williams AD; So A; Conejo-Garcia JR; Plesa G; Young RM; McGettigan S; Campbell J; Pierce RH; Matro JM; DeMichele AM; Clark AS; Cooper LJ; Schuchter LM; Vonderheide RH; June CH
Cancer Immunol Res; 2017 Dec; 5(12):1152-1161. PubMed ID: 29109077
[TBL] [Abstract][Full Text] [Related]
20. T and B cell clonal expansion in Ras-associated lymphoproliferative disease (RALD) as revealed by next-generation sequencing.
Levy-Mendelovich S; Lev A; Rechavi E; Barel O; Golan H; Bielorai B; Neumann Y; Simon AJ; Somech R
Clin Exp Immunol; 2017 Sep; 189(3):310-317. PubMed ID: 28500641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
